Meco BC, Jakobsen K, De Robertis E, Buhre W, Alkış N, Kirkegaard PR, Hägi-Pedersen D, Bubser F, Koch S, Evered LA, Saunders SJ, Caterino M, Paolini F, Berger-Estilita J, and Radtke FM
Background: Postoperative delirium (POD) following surgery is a prevalent and distressing condition associated with adverse patient outcomes and an increased healthcare burden., Objectives: To assess the effectiveness of the Safe Brain Initiative care bundle (SBI-CB) in reducing POD in the postanesthesia care unit (PACU)., Design: A multicenter, quality-improvement initiative with retrospective analysis of collected data., Setting: The study was conducted in the operating rooms and postanesthesia care units (PACUs) of four hospitals across Denmark and Turkey., Patients: The convenience sample of patients were aged ≥18 years, scheduled for surgery, and could communicate verbally. Age, sex, preoperative delirium, and the American Society for Anesthesiology physical status classification were used in statistical methods to control for potential confounding influences., Intervention: The SBI-CB, 18 delirium-reducing recommendations aligned with international guidelines. The intervention included patient education, staff training, coordination meetings across centers, and a dashboard for the monitoring of outcomes in the PACU., Main Outcome Measures: The primary outcome was the POD trend in the PACU during implementation months, assessed through Nu-DESC screening at up to three time points in the PACU. We also examined the length of hospital stay., Results: Data were collected from 18,697 adult patients across four hospitals. Initial POD incidence in the PACU after the first three months was 16.36% across all sites (n = 1021). POD in the PACU was observed across all age groups, with peak incidence in younger (18-35 years) and older (>75 years) patients. General anesthesia and longer surgical duration (>1 h) were identified as significant risk factors for POD in the PACU. Matched patients who experienced POD in the PACU had longer stays in hospital, with a mean increase from 35 to 69 h (p < 0.001). Implementation of the SBI-CB was associated with a decreased risk of POD in the PACU for each month of SBI-CB implementation (adjusted odds ratio 0.96, 95% confidence interval: [0.94, 0.97], p < 0.001)., Conclusions: The presented pragmatic implementation of a multidisciplinary care bundle, encompassing pre-, intra-, and postoperative measures alongside outcome monitoring, has the potential to significantly reduce the incidence of POD in the PACU. Improved patient outcomes may be achieved for general surgical departments with patient cohorts not typically considered at risk for developing POD., Trial Registration: Clinicaltrials.gov, identifier NCT05765162., Competing Interests: Declaration of competing interest SS, MC, and FP are employed at Coreva Scientific GmbH & Co. KG that received compensation for their work. JBE is a member of the ESAIC eLearning and Examinations Committee. She also has received support for travel expenses from Medtronic. WB is the President Elect of the European Society of Anaesthesiology and Intensive Care Medicine (ESAIC) and received fees for a lecture from BD Diagnostics. WB is also the coordinating investigator of the PHOENICS/THEHYS study Fresenius Kabi and ESAIC. EDR received honoraria from Baxter, Fresenius Kabi, MSD, Fisher & Paykel, Drager, and GE health. FMR received unrestricted research and educational grants from Medtronic and is active on the advisory board of GE health. DHP, BCM, FB, KJ, LAE, PRK, NA, and SK claim no competing interests. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Finn M Radtke reports financial support was provided by Medtronic Inc. Finn M Radtke reports a relationship with Coreva Scientific GmbH und Co KG that includes: non-financial support. SS, MC, and FP are Coreva Scientific GmbH & Co. KG employees that received consultancy fees for performing, analyzing, and communicating the work from the Hospital of Nykøbing Falster. FMR received an unrestricted research grant from Medtronic Inc. Medtronic had no scientific input, and no benefits to their products are presented in this work. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)